Assessment of efficacy and safety of imatinib as an adjunct host-targeted therapy for parasite clearance in chloroquine-resistant malaria: a prospective case control study
Abstract Overview Chloroquine-resistant malaria poses a significant treatment challenge, especially in endemic areas. Host-targeted therapies, like tyrosine kinase inhibitors (TKIs) such as imatinib, have shown potential to improve malaria treatment outcomes by disrupting parasite egress from red bl...
| Main Authors: | , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
SpringerOpen
2025-01-01
|
| 丛编: | The Egyptian Journal of Internal Medicine |
| 主题: | |
| 在线阅读: | https://doi.org/10.1186/s43162-025-00399-9 |